Bicycle Therapeutics LtdEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 3.87 USD | 9,159 USD | 3,87 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 13,571 USD | 5 | 5 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 50.373.281 | 7,67 | 4,77 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Bicycle Therapeutics Ltd
Mitarbeiter 288
Handelsplatz NASDAQ
Ticker Symbol BCYC
IPO Datum 2019-05-23
Adresse Portway Building, Cambridge, United Kingdom, CB21 6GS
Webseite https://www.bicycletherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Kevin Lee M.B.A., Ph.D. | CEO & Executive Director |
| 2 | Dr. Michael Skynner B.sc. Ph.d., Ph.D. | Chief Scientific Officer |
| 3 | Mr. Alistair Milnes | Chief Corporate Development Officer |
| 4 | Dr. Christian Heinis | Scientific Founder |
| 5 | Mr. Travis Thompson | Chief Financial Officer |
| 6 | Dr. Jennifer Perry Pharm.D. | Chief Operating Officer |
| 7 | Ms. Stephanie Yao | Senior Vice President of Investor Relations and Corporate Communications |
| 8 | Mr. Zafar Qadir | Chief Legal Officer & General Counsel |
| 9 | Dr. Phil Jeffrey | Senior VP of Pre-Clinical Development |
| 10 | Dr. Michael Charles-Ferguson Hannay | Chief Product & Supply Chain Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 2 | FCPM III SERVICES BV | 0,00% | 0,00 Mio. USD |
| 3 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Long Focus Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 7 | GSK PLC | 0,00% | 0,00 Mio. USD |
| 8 | Principal Financial Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 11 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 12 | Schroder Investment Management Group | 0,00% | 0,00 Mio. USD |
| 13 | Diadema Partners LP | 0,00% | 0,00 Mio. USD |
| 14 | Birchview Capital, LP | 0,00% | 0,00 Mio. USD |
| 15 | Silvercrest Asset Management Group LLC | 0,00% | 0,00 Mio. USD |
| 16 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 17 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 18 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 19 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 20 | BlackRock Inc | 0,00% | 0,00 Mio. USD |